Rhenovia Pharma Language Contact
Search
   
    HomeCompanyScience & TechnologyServices & ProductsInvestors & MarketNews & EventsContact Us    
    Rhenovia Pharma    
   
RSS

Stay connected & subscribe to Rhenovia News Feed

Get English News Feed
Home > News & Events

News & Events

Performing drug testing on the computer instead in bench experiment: Rhenovia presents a new tool of biosimulation at BioPharm America, 15-17 September 2010, Boston.
4 September 2010 - Performing drug testing on the computer instead in bench experiment: Rhenovia presents a new tool of biosimulation at BioPharm America, 15-17 September 2010, Boston.
DID RHENOVIA UNRAVEL THE CAUSE OF ONE OF THE MAJOR SETBACKS OF THE PHARMACEUTICAL INDUSTRY? The Rhenovia team used its modeling and biosimulation platform to explain the failures of NMDA receptor antagonists in stroke.
29 August 2010 - DID RHENOVIA UNRAVEL THE CAUSE OF ONE OF THE MAJOR SETBACKS OF THE PHARMACEUTICAL INDUSTRY? The Rhenovia team used its modeling and biosimulation platform to explain the failures of NMDA receptor antagonists in stroke.
Rhenovia invited by UBIFRANCE to present its unique neuronal biosimulation platform at the French Biotech Tour in Philadelphia, 14 September 2010.
21 August 2010 - Rhenovia invited by UBIFRANCE to present its unique neuronal biosimulation platform at the French Biotech Tour in Philadelphia, 14 September 2010.
August 20, 2010 2:36 AM ET Pharmaceuticals Rhenovia Pharma SAS:Key developments for Rhenovia Pharma cited in Bloomberg Business Week
20 August 2010 - August 20, 2010 2:36 AM ET Pharmaceuticals Rhenovia Pharma SAS:Key developments for Rhenovia Pharma cited in Bloomberg Business Week
Rhenovia hosts the 3rd Biannual Meeting of the 7th PCRD European Program SELFMEM, 6-7 September 2010 at its new headquarters in Mulhouse/France
18 August 2010 - Rhenovia hosts the 3rd Biannual Meeting of the 7th PCRD European Program SELFMEM, 6-7 September 2010 at its new headquarters in Mulhouse/France
Rhenovia simulates neurons for better drugs : demonstration in 2 videos
14 August 2010 - Rhenovia simulates neurons for better drugs : demonstration in 2 videos
Prof. Theodore Berger, Chairman of the Rhenovia Advisory Board participated at IEEE-EMBS Grand Challenges in Neuroengineering
11 August 2010 - Prof. Theodore Berger, Chairman of the Rhenovia Advisory Board participated at IEEE-EMBS Grand Challenges in Neuroengineering
Rhenovia's New Headquarters Inaugurated on July 3, 2010
5 July 2010 - Rhenovia's New Headquarters Inaugurated on July 3, 2010
Inauguration of Rhenovia New Headquarters: July 3, 2010
3 July 2010 - Inauguration of Rhenovia New Headquarters: July 3, 2010
Press Conference: Official Launch of Rhenovia's Epilepsy Program for the Optimization of Antiepileptic Drug Discovery & Development of Pharmaceutical and Biotechnology Companies.
2 June 2010 - Press Conference: Official Launch of Rhenovia's Epilepsy Program for the Optimization of Antiepileptic Drug Discovery & Development of Pharmaceutical and Biotechnology Companies.
Enhance the success rate of your in-licensing activities with the Rhenovia’s new service offer “The Virtual Compound Profiling Program” - Meet Rhenovia at BIO Chicago (3-6 May 2010), French Pavilion #3712
26 April 2010 - Enhance the success rate of your in-licensing activities with the Rhenovia’s new service offer “The Virtual Compound Profiling Program” - Meet Rhenovia at BIO Chicago (3-6 May 2010), French Pavilion #3712
DRUG DISCOVERY Rhenovia wins contract to lead USD 3.75 million biosimulation project: Rhenovia will be present at BIO Chicago, May 3-6, 2010 at booth #3712
16 April 2010 - DRUG DISCOVERY Rhenovia wins contract to lead USD 3.75 million biosimulation project: Rhenovia will be present at BIO Chicago, May 3-6, 2010 at booth #3712
Rhenovia will take the lead RHENEPI, a project of 2.5 million Euro. Objective: To develop a platform biosimulation of seizures to identify and test new drugs and optimize existing ones.
15 April 2010 - Rhenovia will take the lead RHENEPI, a project of 2.5 million Euro. Objective: To develop a platform biosimulation of seizures to identify and test new drugs and optimize existing ones.
Rhenovia to lead US$3.75m biosimulation project
15 April 2010 - Rhenovia to lead US$3.75m biosimulation project
The platform of biosimulation Rhenovia is used to simulate the neural transmission which leads to erratic seizures
15 April 2010 - The platform of biosimulation Rhenovia is used to simulate the neural transmission which leads to erratic seizures
159 press articles today regarding the news Rhenovia
14 April 2010 - 159 press articles today regarding the news Rhenovia
Collaborative project extends Rhenovia's innovative CNS biosimulation platform
13 April 2010 - Collaborative project extends Rhenovia's innovative CNS biosimulation platform
Rhenovia at BIO Chicago, May 3-6, 2010: discover the new applications of Rhenovia's biosimulation platform for the optimization of your Drug Discovery
8 April 2010 - Rhenovia at BIO Chicago, May 3-6, 2010: discover the new applications of Rhenovia's biosimulation platform for the optimization of your Drug Discovery
Meet with Rhenovia at the CHI's Combination Drug Therapies Conference (April 13-14, 2010, Philadelphia)
5 April 2010 - Meet with Rhenovia at the CHI's Combination Drug Therapies Conference (April 13-14, 2010, Philadelphia)
Rhenovia awarded by the academic authorities and the Region Alsace for its commitment to training its employees and gets the trophy in 2010
4 April 2010 - Rhenovia awarded by the academic authorities and the Region Alsace for its commitment to training its employees and gets the trophy in 2010
Pre-Announcement: Rhenovia will participate at the partnering at Bio Chicago (3-6 May 2010) and be present at the French Pavillion. One-to-one partnering can already be requested to serge.bischoff@rhenovia.com .
22 March 2010 - Pre-Announcement: Rhenovia will participate at the partnering at Bio Chicago (3-6 May 2010) and be present at the French Pavillion. One-to-one partnering can already be requested to serge.bischoff@rhenovia.com .
Rhenovia Pharma among the 75 projects of French clusters of competitiveness
17 March 2010 - Rhenovia Pharma among the 75 projects of French clusters of competitiveness
The Mechanisms of Memory:Rhenovia CSO and USC College's Pr. Michel Baudry and graduate student Sohila Zadran brought 40 years of research to a pinnacle with their breakthroughs in the science of learning and memory.
15 March 2010 - The Mechanisms of Memory:Rhenovia CSO and USC College's Pr. Michel Baudry and graduate student Sohila Zadran brought 40 years of research to a pinnacle with their breakthroughs in the science of learning and memory.
Rhenovia awarded 'entrepreneurs of exception' is selected by OSEO to join the Club Excellence
9 March 2010 - Rhenovia awarded 'entrepreneurs of exception' is selected by OSEO to join the Club Excellence
Discover Rhenovia’s breakthrough biosimulation platform to maximize your Drug Pipeline at Bio-Europe Spring in Barcelona (Spain) March 8-10, 2010
8 March 2010 - Discover Rhenovia’s breakthrough biosimulation platform to maximize your Drug Pipeline at Bio-Europe Spring in Barcelona (Spain) March 8-10, 2010
SELFMEM/ Self-assembling Polymer Membranes; a EU-FP7 co-funded project / Grant Agreement NMP3-SL-2009-228652 ( 2nd semiannual meeting ) will be held at University of Cyprus on 4 and 5 March 2010 .
5 March 2010 - SELFMEM/ Self-assembling Polymer Membranes; a EU-FP7 co-funded project / Grant Agreement NMP3-SL-2009-228652 ( 2nd semiannual meeting ) will be held at University of Cyprus on 4 and 5 March 2010 .
The CSO of Rhenovia , Pr. Michel Baudry awarded Dr. Honoris Causa from the University of Provence Aix Marseille
4 February 2010 - The CSO of Rhenovia , Pr. Michel Baudry awarded Dr. Honoris Causa from the University of Provence Aix Marseille
Join Rhenovia at the Maison de l’Alsace, on the Champs Elysées in Paris on Januray 27, 2010.
27 January 2010 - Join Rhenovia at the Maison de l’Alsace, on the Champs Elysées in Paris on Januray 27, 2010.
Rhenovia represented by Alsace BioValley at BioPartnering North America in Vancouver
25 January 2010 - Rhenovia represented by Alsace BioValley at BioPartnering North America in Vancouver
Estrogen and memory: a
10 December 2009 - Estrogen and memory: a "calpain" step closer: a new study: Pr. Michel Baudry,CSO of Rhenovia, is senior co-author of the study, which implies that the hormonal description of estrogen needs revisiting.
Rhenovia migrates its headquarters to its new premises
25 November 2009 - Rhenovia migrates its headquarters to its new premises
NewYork, Last 14-15 of September:Alzheimer's Drug Discovery Fondation Hosted the 10th International Conference on Alzheimer's Drug Discovery,Big Success for Rhenovia Pharma The 10th International Conference on Alzheimer's Drug Discovery was sponsored by Pfizer Inc.; Elan Pharmaceuticals; Martek Biosciences Corporation; Schering-Plough; Allon Therapeutics, Inc.; JSW Lifesciences; Abbott; The American Journal of Geriatric Pharmacotherapy; Apredica; Intra-Cellular Therapies, Inc.; and Rhenovia Pharma.
14 November 2009 - NewYork, Last 14-15 of September:Alzheimer's Drug Discovery Fondation Hosted the 10th International Conference on Alzheimer's Drug Discovery,Big Success for Rhenovia Pharma The 10th International Conference on Alzheimer's Drug Discovery was sponsored by Pfizer Inc.; Elan Pharmaceuticals; Martek Biosciences Corporation; Schering-Plough; Allon Therapeutics, Inc.; JSW Lifesciences; Abbott; The American Journal of Geriatric Pharmacotherapy; Apredica; Intra-Cellular Therapies, Inc.; and Rhenovia Pharma.
The collaborative project Rhenepi of Rhenovia Pharma wins today labeling of Biovalley competitivity center (on a worldwide scale)
10 November 2009 - The collaborative project Rhenepi of Rhenovia Pharma wins today labeling of Biovalley competitivity center (on a worldwide scale)
Pr. Pierre Braunstein;member of the Scientific Council of Rhenovia as keynote speaker at the Inaugural (1st) International Conference on Molecular & Functional Catalysis (ICMFC –1) @ Singapore
18 October 2009 - Pr. Pierre Braunstein;member of the Scientific Council of Rhenovia as keynote speaker at the Inaugural (1st) International Conference on Molecular & Functional Catalysis (ICMFC –1) @ Singapore
Looking Forward to Pharma's Decade of Predictive Efficacy: Rhenovia mentioned as a champion in an article published in BioPharma Today
14 October 2009 - Looking Forward to Pharma's Decade of Predictive Efficacy: Rhenovia mentioned as a champion in an article published in BioPharma Today
Meet Rhenovia: Chicago 39th annual meeting of the Society for Neuroscience.
10 October 2009 - Meet Rhenovia: Chicago 39th annual meeting of the Society for Neuroscience.
Rhenovia obtains significant research contract in the frame of the European 7PCRD
30 September 2009 - Rhenovia obtains significant research contract in the frame of the European 7PCRD
Rhenovia participates at the French economical mission in Seoul and Tokyo on October 3-9, 2009.
26 September 2009 - Rhenovia participates at the French economical mission in Seoul and Tokyo on October 3-9, 2009.
Dr.Xiaoning Bi, MD, strengthens team Rhenovia Pharma
24 September 2009 - Dr.Xiaoning Bi, MD, strengthens team Rhenovia Pharma
Toward Replacement Parts for the Brain: A best seller of the Rhenovia Scientific chairman ( Pr.Ted Berger)
21 September 2009 - Toward Replacement Parts for the Brain: A best seller of the Rhenovia Scientific chairman ( Pr.Ted Berger)
OSEO supports Rhenovia Pharma ( In French) OSEO has three jobs: * support for innovation, * guarantee bank loans and equity investors, * the partnership funding.
15 September 2009 - OSEO supports Rhenovia Pharma ( In French) OSEO has three jobs: * support for innovation, * guarantee bank loans and equity investors, * the partnership funding.
Biosimulation: The partnership program Rheddos of Rhenovia cited in Wikipedia
21 August 2009 - Biosimulation: The partnership program Rheddos of Rhenovia cited in Wikipedia
In French: © Dernières Nouvelles d'Alsace, Jeudi 13 Août 2009:Business angels invest in Rhenovia
16 August 2009 - In French: © Dernières Nouvelles d'Alsace, Jeudi 13 Août 2009:Business angels invest in Rhenovia
Two USC faculty members and the French drug discovery company Rhenovia Pharma have been awarded a biomedical research partnership by the National Institutes of Health.The grant will support joint research by the three partners for four years, with the total amount of funding reaching $2.3 million.
16 August 2009 - Two USC faculty members and the French drug discovery company Rhenovia Pharma have been awarded a biomedical research partnership by the National Institutes of Health.The grant will support joint research by the three partners for four years, with the total amount of funding reaching $2.3 million.
Meet with Rhenovia :BioValley-Stammtisch Freiburg in Germany: Rhenovia Pharma: Innovative Drug Discovery and Development by a Breakthrough Biosimulation Technology
15 August 2009 - Meet with Rhenovia :BioValley-Stammtisch Freiburg in Germany: Rhenovia Pharma: Innovative Drug Discovery and Development by a Breakthrough Biosimulation Technology
Rhenovia registered in Bionity.com
15 August 2009 - Rhenovia registered in Bionity.com
ECOBANK says today: France: The eastern and northern regions have companies with strong potential; Example: Rhenovia in Mulhouse
11 August 2009 - ECOBANK says today: France: The eastern and northern regions have companies with strong potential; Example: Rhenovia in Mulhouse
Science Business News : Rhenovia Pharma | France | Funding Rhenovia raises €390K in angel funding
7 August 2009 - Science Business News : Rhenovia Pharma | France | Funding Rhenovia raises €390K in angel funding
From
7 August 2009 - From "Wherepharmameets News":Rhenovia Closes First Round of Angel Funding
NIH to Fund Bioinformatics Small Business Grants August 05, 2009 A trans-NIH program will support SBIR, STTR, and research grants in computational biology. France's Rhenovia Pharma Raises $540K to Advance USC Simulation Tech as Drug-Discovery Tool August 04, 2009 By Ben Butkus
5 August 2009 - NIH to Fund Bioinformatics Small Business Grants August 05, 2009 A trans-NIH program will support SBIR, STTR, and research grants in computational biology. France's Rhenovia Pharma Raises $540K to Advance USC Simulation Tech as Drug-Discovery Tool August 04, 2009 By Ben Butkus
Rhenovia and USC to Collect $2.3M Grant to Study Brain Functions and Disorders GEN News Highlights
4 August 2009 - Rhenovia and USC to Collect $2.3M Grant to Study Brain Functions and Disorders GEN News Highlights
Rhenovia signs research contract with USC and NIH
4 August 2009 - Rhenovia signs research contract with USC and NIH
Extra on line magazine Capital (August 2009) Rhenovia ranked one of the most promising start-up in France
1 August 2009 - Extra on line magazine Capital (August 2009) Rhenovia ranked one of the most promising start-up in France
Meet with the Rhenovia Pharma Team at the 39th Meeting of the Society for Neuroscience, October 17-21, 2009, Chicago, Illinois, USA
1 August 2009 - Meet with the Rhenovia Pharma Team at the 39th Meeting of the Society for Neuroscience, October 17-21, 2009, Chicago, Illinois, USA
Rhenovia and USC labs in US$2.3m biosimulation research programme
1 August 2009 - Rhenovia and USC labs in US$2.3m biosimulation research programme
176 articles have been published this July in the international business press highlighting successful cases Rhenovia Pharma
1 August 2009 - 176 articles have been published this July in the international business press highlighting successful cases Rhenovia Pharma
Rhenovia wins angel funding (art.in Growthbusiness.UK 31.07.09)
31 July 2009 - Rhenovia wins angel funding (art.in Growthbusiness.UK 31.07.09)
Dow Jones Industrial Average:Rhenovia Pharma SAS, a biopharmaceutical company developing drugs for Alzheimer's and other brain diseases, said it has raised EUR390,000 ($542,000) in a first round of angel funding..
31 July 2009 - Dow Jones Industrial Average:Rhenovia Pharma SAS, a biopharmaceutical company developing drugs for Alzheimer's and other brain diseases, said it has raised EUR390,000 ($542,000) in a first round of angel funding..
Rhenovia obtains significant research contract with the US National Institutes of Health (NIH)
31 July 2009 - Rhenovia obtains significant research contract with the US National Institutes of Health (NIH)
Pharmalive.com. Rhenovia obtains significant research contract with the US National Institutes of Health (NIH)
30 July 2009 - Pharmalive.com. Rhenovia obtains significant research contract with the US National Institutes of Health (NIH)
USC partners with French drug discovery company on computer modeling effort
30 July 2009 - USC partners with French drug discovery company on computer modeling effort
Jul 29 2009, 10:22 AM EST Rhenovia and USC to Collect $2.3M Grant to Study Brain Functions and Disorders GEN News Highlights
30 July 2009 - Jul 29 2009, 10:22 AM EST Rhenovia and USC to Collect $2.3M Grant to Study Brain Functions and Disorders GEN News Highlights
Rhenovia ranked one of the most promising start-up in France
21 July 2009 - Rhenovia ranked one of the most promising start-up in France
RHENOVIA PHARMA has completed successfully its first round table of private fund raising.
11 July 2009 - RHENOVIA PHARMA has completed successfully its first round table of private fund raising.
Rhenovia opens its biosimulation platform...
10 July 2009 - Rhenovia opens its biosimulation platform...
Meet with the Rhenovia Pharma Team at the 39th Meeting of the Society for Neuroscience, October 17-21, 2009, Chicago, Illinois, USA
10 July 2009 - Meet with the Rhenovia Pharma Team at the 39th Meeting of the Society for Neuroscience, October 17-21, 2009, Chicago, Illinois, USA
Rhenovia Closes First Round of Angel Funding
7 July 2009 - Rhenovia Closes First Round of Angel Funding
Rhenovia funded by the European FP7 Research Programme
6 July 2009 - Rhenovia funded by the European FP7 Research Programme
Rhenovia Pharma at Bio Atlanta international convention 18-21 of May
18 May 2009 - Rhenovia Pharma at Bio Atlanta international convention 18-21 of May
BME Part of NIH-Funded $2.3M Partnership to Research Glutamate Receptor Activity
26 April 2009 - BME Part of NIH-Funded $2.3M Partnership to Research Glutamate Receptor Activity
Visit of the french Secretary of State for Development of Digital Economy,and meeting with Dr. Serge Bischoff
13 April 2009 - Visit of the french Secretary of State for Development of Digital Economy,and meeting with Dr. Serge Bischoff
meet Rhenovia at Bio Square, March 9-11 Lyon congress center
9 March 2009 - meet Rhenovia at Bio Square, March 9-11 Lyon congress center
Rhenovia at Neuroscience 2008 Washington DC: 15-19 November
15 November 2008 - Rhenovia at Neuroscience 2008 Washington DC: 15-19 November
Rhenovia at MIPTEC Basel 14-16 October 2008
14 October 2008 - Rhenovia at MIPTEC Basel 14-16 October 2008
EUROBIO 2008 Paris: Meet and partner with Rhenovia in Paris 7-9 October
7 October 2008 - EUROBIO 2008 Paris: Meet and partner with Rhenovia in Paris 7-9 October
Meet with Rhenovia at BioContact Quebec October 1-3, 2008
1 October 2008 - Meet with Rhenovia at BioContact Quebec October 1-3, 2008
Partnership between Altran Est (The european leader in innovation consulting) and Rhenovia Pharma
19 September 2008 - Partnership between Altran Est (The european leader in innovation consulting) and Rhenovia Pharma
Dr. Serge Braun : New scientific advisory board member of Rhenovia
25 July 2008 - Dr. Serge Braun : New scientific advisory board member of Rhenovia
Eurostars label for Rhenovia Pharma
22 July 2008 - Eurostars label for Rhenovia Pharma
Rhenovia and the Blue Brain Project Meeting: in Geneva
10 July 2008 - Rhenovia and the Blue Brain Project Meeting: in Geneva
Rhenovia invited by the French government at the European Innovation Conférence
7 July 2008 - Rhenovia invited by the French government at the European Innovation Conférence
Rhenovia presents the EONS-RHENOMS platform at the 3rd Frontiers in Biomedical Devices Conference, a congress of the ASME, the American Society for Medical Engineering
18 June 2008 - Rhenovia presents the EONS-RHENOMS platform at the 3rd Frontiers in Biomedical Devices Conference, a congress of the ASME, the American Society for Medical Engineering
Rhenovia at BioBAC Conference Basel
4 June 2008 - Rhenovia at BioBAC Conference Basel
just married
23 May 2008 - just married
Rhenovia invited to Region Alsace
21 April 2008 - Rhenovia invited to Region Alsace
Participation of Rhenovia: April 17, 2008, 3rd Leadership Course: European Course for Life Sciences Executives
17 April 2008 - Participation of Rhenovia: April 17, 2008, 3rd Leadership Course: European Course for Life Sciences Executives
Pr. Henry Markram; New scientific advisory board member of Rhenovia
8 April 2008 - Pr. Henry Markram; New scientific advisory board member of Rhenovia
Rhenovia at BioSquare Basel 2008
12 March 2008 - Rhenovia at BioSquare Basel 2008
Highly Cited Researchers: Pr. Michel Baudry co-founder of Rhenovia
28 February 2008 - Highly Cited Researchers: Pr. Michel Baudry co-founder of Rhenovia
Partnership with the Association Alsace Alzheimer 68
21 February 2008 - Partnership with the Association Alsace Alzheimer 68
15 October 2007 - Novel Drug Discovery Strategy for Alzheimer's and Other Brain Diseases
Colloque ECRIN PARIS: Vers une standardisation en biologie : Enjeux scientifiques et économiques
9 October 2007 - Colloque ECRIN PARIS: Vers une standardisation en biologie : Enjeux scientifiques et économiques
Biovalley news
10 July 2007 - Biovalley news
 
News

News & Events

Sep 2010 - Performing drug testing on the computer instead in bench experiment: Rhenovia presents a new tool of biosimulation at BioPharm America, 15-17 September 2010, Boston.

Aug 2010 - DID RHENOVIA UNRAVEL THE CAUSE OF ONE OF THE MAJOR SETBACKS OF THE PHARMACEUTICAL INDUSTRY? The Rhenovia team used its modeling and biosimulation platform to explain the failures of NMDA receptor antagonists in stroke.

Press Releases

Oct 2009 - Meet with the Rhenovia Pharma Team at the 39th Meeting of the Society for Neuroscience, October 17-21, 2009, Chicago, Illinois, USA

Sep 2009 - 26 September 2009 - Rhenovia participates at the French economical mission in Seoul and Tokyo on October 3-9, 2009.

Publications

Computational studies of NMDA receptors: differential effects of neuronal activity on efficacy of competitive and noncompetitive antagonists

Brain-computer interfaces ( An international assessment of research and development trends) Auteur(s) : BERGER T.W, MCFARLAND D.J., TAYLOR D.M Date de parution: 09-2008 Langue : ANGLAIS

Newsletters

Rhenovia Receives €2.5M to Further Develop Its Biosimulation Platform GEN News Highlights

Newsletter April 2008

    
    © 2010 Rhenovia Pharma - Limited. All Rights Reserved. Use of this website is governed by our Terms of Use.